Table 1 Demographics, blood pressure profiles, treatments and outcomes of patients
Controlled Hypertension (n = 115) | Uncontrolled Hypertension (n = 236) | P value | Non-Severe Covid-19 (n = 137) | Severe covid-19 (n = 214) | P value | |
|---|---|---|---|---|---|---|
Demographics | ||||||
Age, year | 52 ± 17 | 55 ± 26 | 0.473 | 50 ± 27 | 56 ± 30 | 0.053 |
Sex, men | 41.2% | 58.8% | 0.033 | 51.2% | 49.9% | 0.231 |
BP on admission | ||||||
SBP, mmHg | 126 ± 18 | 144 ± 31 | 0.007 | 128 ± 10 | 130 ± 22 | 0.144 |
DBP, mmHg | 81 ± 11 | 92 ± 18 | 0.043 | 80 ± 9 | 80 ± 15 | 0.556 |
MAP, mmHg | 96 ± 13 | 97 ± 16 | 0.632 | 99 ± 20 | 97 ± 23 | 0.473 |
Comobidities | ||||||
Diabetes mellitus | 32.9% | 25.6% | 0.063 | 14.6% | 34.5% | 0.003 |
CAD | 32.9% | 17.6% | 0.556 | 32.9% | 27.6% | 0.556 |
CKD | 14.1% | 33.3% | 0.188 | 14.1% | 33.3% | 0.188 |
Heart failure | 10.6% | 17.6% | 0.631 | 10.6% | 17.6% | 0.631 |
Antihypertensive drugs on admission | ||||||
AdCEis/ARBs | 60.5% | 64.2% | 0.152 | 60% | 62.3% | 0.209 |
Beta blockers | 18.5% | 25% | 0.131 | 25.2% | 22.3% | 0.440 |
CCBs | 42% | 43.1% | 0.665 | 44.5% | 46.8% | 0.556 |
Diuretics | 22.3% | 19.3% | 0.154 | 23.1% | 18,3% | 0.188 |
Any of drugs above | 12.3% | 27.9% | 0.045 | 33.4% | 27% | 0.052 |
Other medications | ||||||
Glucocorticoid | 86.9% | 83.8% | 0.822 | 87.5% | 92.5% | 0.082 |
Anticoagulant | 52.1% | 55.1% | 0.898 | 36.49% | 84.1% | 0.000 |
BP Profile during hospitalization | ||||||
MAPCV | 2.1 ± 2.85 | 3.27 ± 4.9 | 0.002 | 2.9 ± 3.77 | 1.88 ± 2.42 | 0.000 |
High BPV | 40.2% | 59.8% | 0.003 | 68.4% | 31.6% | 0.005 |
Outcome | ||||||
In-hospital mortality | 16.52% | 46.08% | 0.003 | 8.02% | 37.8% | 0.000 |
